HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Buy All Versions of this Article: fj.09-129874v1 23/9/2978    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Zhou, H.-f. Articles by Pham, C. T. N. PubMed PubMed Citation Articles by Zhou, H.-f. Articles by Pham, C. T. N.

_vβ₃-Targeted nanotherapy suppresses inflammatory arthritis in mice

Hui-fang Zhou^*,1, Happy W. Chan^,1, Samuel A. Wickline, Gregory M. Lanza and Christine T. N. Pham^*,2

^* Division of Rheumatology and

Division of Cardiology, Washington University School of Medicine, St. Louis, Missouri, USA; and

Division of Rheumatology, University of California at Davis School of Medicine, Davis, California, USA

² Correspondence: 660 South Euclid Ave., Box 8045, St. Louis, MO 63110, USA. E-mail cpham{at}im.wustl.edu

The purpose of this study was to assess whether an alternative treatment approach that targets angiogenesis, delivered through ligand-targeted nanotherapy, would ameliorate inflammatory arthritis. Arthritis was induced using the K/BxN mouse model of inflammatory arthritis. After arthritis was clearly established, mice received three consecutive daily doses of _vβ₃-targeted fumagillin nanoparticles. Control groups received no treatment or _vβ₃-targeted nanoparticles without drugs. Disease score and paw thickness were measured daily. Mice that received _vβ₃-targeted fumagillin nanoparticles showed a significantly lower disease activity score (mean score of 1.4±0.4; P<0.001) and change in ankle thickness (mean increase of 0.17±0.05 mm; P<0.001) 7 d after arthritis induction, whereas the group that received _vβ₃-targeted nanoparticles without drugs exhibited a mean arthritic score of 9.0 ± 0.3 and mean change in ankle thickness of 1.01 ± 0.09 mm. Meanwhile, the group that received no treatment showed a mean arthritic score of 9.8 ± 0.5 and mean change in ankle thickness of 1.05 ± 0.10 mm. Synovial tissues from animals treated with targeted fumagillin nanoparticles also showed significant decrease in inflammation and angiogenesis and preserved proteoglycan integrity. Ligand-targeted nanotherapy to deliver antiangiogenic agents may represent an effective way to treat inflammatory arthritis.—Zhou, H.-F., Chan, H. W., Wickline, S. A., Lanza, G. M., Pham, C. T. N. _vβ₃-Targeted nanotherapy suppresses inflammatory arthritis in mice.

Key Words: angiogenesis • K/BxN mouse model • perfluorocarbon nanoparticles • systemic drug delivery